ENALAPRIL
DrugBank ID: db00584
DrugCentral: enalapril
Synonymous :(s)-1-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-l-proline | (s)-1-{(s)-2-[1-((s)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid | 1-(n-((s)-1-carboxy-3-phenylpropyl)-l-alanyl)-l-proline 1’-ethyl ester | ánalapril | enalapril | enalaprila | enalaprilum
Drug Sentece Context
Table 1. Analysis of context sentence of enalapril gene in 4 abstracts.
| pmid | sentence |
|---|---|
| 32213760 | Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. |
| 32799423 | ACE2 was increased with only a few of the tested medication groups, namely the renin-angiotensin inhibitors, such as enalapril, antibacterial agents, such as nitrofurantoin, and the proton pump inhibitor, omeprazole. |
| 33260592 | Preliminary docking was more optimal to ACE2 than the known typical angiotensin-converting enzyme 1 (ACE1) inhibitor (enalapril) and quite comparable to known or presumed ACE2 inhibitors. |
| 33447763 | Treatment of primary human hepatocytes with captopril, but not enalapril, significantly increased ACE2 expression. […] A similar pattern of ACE2 expression was found following the in vitro treatments of rat primary cells with captopril and enalapril. |